Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDGSK Plc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | $1.12 | $1.25 | $1.17 |
| Q2 2026 | 3 | $1.19 | $1.29 | $1.24 |
| Q3 2026 | 1 | $1.40 | $1.49 | $1.45 |
| Q4 2026 | 1 | $0.86 | $0.91 | $0.89 |
| Q1 2027 | 1 | $1.35 | $1.44 | $1.40 |
| Q2 2027 | 1 | $1.45 | $1.54 | $1.50 |
| Q3 2027 | 1 | $1.66 | $1.77 | $1.73 |
| Q4 2027 | 1 | $0.86 | $0.92 | $0.89 |
GSK Plc Earnings Date And Information
GSK Plc last posted its earnings results on Wednesday, February 4th, 2026. The company reported $0.68 earnings per share for the quarter, topping analysts' consensus estimates of $0.64 by $0.04. The company had revenue of 8.51 B for the quarter and had revenue of 31.95 B for the year. GSK Plc has generated $3 earnings per share over the last year ($2.72 diluted earnings per share) and currently has a price-to-earnings ratio of 15.65. GSK Plc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
GSK Plc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/04/2026 | Q4 2025 | $0.64 | $0.32 | -0.32 | $15.35 B | $8.51 B |
| 10/29/2025 | Q3 2025 | N/A | $1.00 | N/A | N/A | $8.55 B |
| 07/30/2025 | Q2 2025 | N/A | $0.72 | N/A | $14.30 B | $7.99 B |
| 04/30/2025 | Q1 2025 | $1.08 | $0.80 | -0.28 | $12.57 B | $7.52 B |
| 03/03/2025 | Q4 2024 | N/A | $0.20 | N/A | $11.93 B | $8.12 B |
| 10/30/2024 | Q3 2024 | $1.16 | -$0.03 | -1.19 | $13.78 B | $8.01 B |
| 06/28/2024 | Q2 2024 | N/A | $0.58 | N/A | $12.11 B | $7.88 B |
| 03/30/2024 | Q1 2024 | N/A | $0.52 | N/A | $11.16 B | $7.36 B |
| 12/30/2023 | Q4 2023 | N/A | $0.17 | N/A | N/A | $8.05 B |
| 09/29/2023 | Q3 2023 | N/A | $0.72 | N/A | N/A | $8.15 B |
| 06/29/2023 | Q2 2023 | N/A | $0.80 | N/A | N/A | $7.18 B |
| 03/31/2023 | Q1 2023 | N/A | $0.74 | N/A | N/A | $6.95 B |
| 12/31/2022 | Q4 2022 | N/A | $0.74 | N/A | N/A | $7.38 B |
| 09/30/2022 | Q3 2022 | N/A | $0.38 | N/A | N/A | $7.83 B |
| 06/30/2022 | Q2 2022 | N/A | $0.42 | N/A | N/A | $6.93 B |
| 03/31/2022 | Q1 2022 | N/A | $0.90 | N/A | N/A | $7.19 B |
| 12/31/2021 | Q4 2021 | N/A | $0.38 | N/A | N/A | $9.53 B |
| 09/30/2021 | Q3 2021 | N/A | $0.58 | N/A | N/A | $6.63 B |
| 06/30/2021 | Q2 2021 | N/A | $0.70 | N/A | N/A | $5.84 B |
| 03/31/2021 | Q1 2021 | N/A | $0.54 | N/A | N/A | $7.42 B |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
GSK Plc Earnings: FAQ's
In the previous quarter, GSK Plc (:GSK) reported $0.68 earnings per share (EPS) to beat the analysts' consensus estimate of $0.64 by $0.04.
The conference call for GSK Plc's latest earnings report can be listened to online.
The conference call transcript for GSK Plc's latest earnings report can be read online.
GSK Plc (:GSK) has a recorded annual revenue of $31.95 B.
GSK Plc (:GSK) has a recorded net income of $5.59 B.GSK Plc has generated $2.76 earnings per share over the last four quarters.
GSK Plc (:GSK) has a price-to-earnings ratio of 15.65 and price/earnings-to-growth ratio is 3.55.